The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Fertility Preservation in Patients With Cancer: ASCO Clinical Practice Guideline Update
Abstract
Purpose: To provide current recommendations about fertility preservation for adults and children with cancer. Methods: A systematic review of the literature published from January 2013 to March 2017 was completed using PubMed and the Cochrane Library. An Update Panel reviewed the identified publications. Results: There were 61 publications identified and reviewed. None of these publications prompted a significant change in the 2013 recommendations. Recommendations: Health care providers should initiate the discussion on the possibility of infertility with patients with cancer treated during their reproductive years or with parents/guardians of children as early as possible. Providers should be prepared to discuss fertility preservation options and/or to refer all potential patients to appropriate reproductive specialists. Although patients may be focused initially on their cancer diagnosis, providers should advise patients regarding potential threats to fertility as early as possible in the treatment process so as to allow for the widest array of options for fertility preservation. The discussion should be documented. Sperm, oocyte, and embryo cryopreservation are considered standard practice and are widely available. There is conflicting evidence to recommend gonadotrophin-releasing hormone agonists (GnRHa) and other means of ovarian suppression for fertility preservation. The Panel recognizes that, when proven fertility preservation methods are not feasible, and in the setting of young women with breast cancer, GnRHa may be offered to patients in the hope of reducing the likelihood of chemotherapy-induced ovarian insufficiency. GnRHa should not be used in place of proven fertility preservation methods. The panel notes that the field of ovarian tissue cryopreservation is advancing quickly and may evolve to become standard therapy in the future. Additional information is available at www.asco.org/survivorship-guidelines .
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Coates, A. S., Winer, E. P., Goldhirsch, A., Gelber, R. D., Gnant, M., Piccart-Gebhart, M., Thürlimann, B., Senn, H.-J., André, F., Baselga, J., et al. (2015) · Annals of Oncology · doi:10.1093/annonc/mdv221 · Cited by 1,827
Self-citationLoren, A. W., Mangu, P. B., Beck, L. N., Brennan, L., Magdalinski, A. J., Partridge, A. H., Quinn, G., Wallace, W. H., & Oktay, K. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2013.49.2678 · Cited by 1,611
Self-citationSchnipper, L. E., Davidson, N. E., Wollins, D. S., Tyne, C., Blayney, D. W., Blum, D., Dicker, A. P., Ganz, P. A., Hoverman, J. R., Langdon, R., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2015.61.6706 · Cited by 912
How Quickly Do Systematic Reviews Go Out of Date? A Survival Analysis
Shojania, K. G., Sampson, M., Ansari, M. T., Ji, J., Doucette, S., & Moher, D. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-147-4-200708210-00179 · Cited by 838
Peccatori, F. A., Azim, H. A., Orecchia, R., Hoekstra, H. J., Pavlidis, N., Kesic, V., & Pentheroudakis, G. (2013) · Annals of Oncology · doi:10.1093/annonc/mdt199 · Cited by 790
Schnipper, L. E., Davidson, N. E., Wollins, D. S., Blayney, D. W., Dicker, A. P., Ganz, P. A., Hoverman, J. R., Langdon, R., Lyman, G. H., Meropol, N. J., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2016.68.2518 · Cited by 655
American Society of Clinical Oncology Guidance Statement: The Cost of Cancer Care
Meropol, N. J., Schrag, D., Smith, T. J., Mulvey, T. M., Langdon, R. M., Blum, D., Ubel, P. A., & Schnipper, L. E. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.23.1183 · Cited by 638
Patient-clinician communication: American Society of Clinical Oncology consensus guideline
Gilligan, T., Coyle, N., Frankel, R. M., Berry, D. L., Bohlke, K., Epstein, R. M., Finlay, E., Jackson, V. A., Lathan, C. S., Loprinzi, C. L., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2017.75.2311 · Cited by 610
Goserelin for Ovarian Protection during Breast-Cancer Adjuvant Chemotherapy
Moore, H. C. F., Unger, J. M., Phillips, K.-A., Boyle, F., Hitre, E., Porter, D., Francis, P. A., Goldstein, L. J., Gomez, H. L., Vallejos, C. S., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1413204 · Cited by 553
Self-citationCost Sharing and Adherence to Tyrosine Kinase Inhibitors for Patients With Chronic Myeloid Leukemia
Dusetzina, S. B., Winn, A. N., Abel, G. A., Huskamp, H. A., & Keating, N. L. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.52.9123 · Cited by 500
Gerber, B., von Minckwitz, G., Stehle, H., Reimer, T., Felberbaum, R., Maass, N., Fischer, D., Sommer, H. L., Conrad, B., Ortmann, O., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.32.5704 · Cited by 297
Patient and Plan Characteristics Affecting Abandonment of Oral Oncolytic Prescriptions
Streeter, S. B., Schwartzberg, L., Husain, N., & Johnsrud, M. (2011) · Journal of Oncology Practice · doi:10.1200/jop.2011.000316 · Cited by 248
Demeestere, I., Brice, P., Peccatori, F. A., Kentos, A., Dupuis, J., Zachee, P., Casasnovas, O., Van Den Neste, E., Dechene, J., De Maertelaer, V., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2015.65.8864 · Cited by 240
Meirow, D., Ra'anani, H., Shapira, M., Brenghausen, M., Derech Chaim, S., Aviel-Ronen, S., Amariglio, N., Schiff, E., Orvieto, R., & Dor, J. (2016) · Fertility and Sterility · doi:10.1016/j.fertnstert.2016.04.031 · Cited by 239
Munster, P. N., Moore, A. P., Ismail-Khan, R., Cox, C. E., Lacevic, M., Gross-King, M., Xu, P., Carter, W. B., & Minton, S. E. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.34.6890 · Cited by 238
Current Success and Efficiency of Autologous Ovarian Transplantation: A Meta-Analysis
Pacheco, F., & Oktay, K. (2017) · Reproductive Sciences · doi:10.1177/1933719117702251 · Cited by 234
Self-citationLambertini, M., Ceppi, M., Poggio, F., Peccatori, F. A., Azim, H. A., Ugolini, D., Pronzato, P., Loibl, S., Moore, H. C. F., Partridge, A. H., et al. (2015) · Annals of Oncology · doi:10.1093/annonc/mdv374 · Cited by 228
Self-citationSecond international consensus guidelines for breast cancer in young women (BCY2)
Paluch-Shimon, S., Pagani, O., Partridge, A. H., Bar-Meir, E., Fallowfield, L., Fenlon, D., Friedman, E., Gelmon, K., Gentilini, O., Geraghty, J., et al. (2016) · The Breast · doi:10.1016/j.breast.2015.12.010 · Cited by 227
Self-citation(2008) · Cited by 225
Jadoul, P., Guilmain, A., Squifflet, J., Luyckx, M., Votino, R., Wyns, C., & Dolmans, M. M. (2017) · Human Reproduction · doi:10.1093/humrep/dex040 · Cited by 208
Lambertini, M., Boni, L., Michelotti, A., Gamucci, T., Scotto, T., Gori, S., Giordano, M., Garrone, O., Levaggi, A., Poggio, F., et al. (2015) · JAMA · doi:10.1001/jama.2015.17291 · Cited by 205
Munhoz, R. R., Pereira, A. A. L., Sasse, A. D., Hoff, P. M., Traina, T. A., Hudis, C. A., & Marques, R. J. (2015) · JAMA Oncology · doi:10.1001/jamaoncol.2015.3251 · Cited by 160
Leonard, R. C. F., Adamson, D. J. A., Bertelli, G., Mansi, J., Yellowlees, A., Dunlop, J., Thomas, G. A., Coleman, R. E., & Anderson, R. A. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx184 · Cited by 159
Elgindy, E. A., El-Haieg, D. O., Khorshid, O., Ismail, E. I., Abdelgawad, M. O., Sallam, H. N., & Abou-Setta, A. M. (2013) · Obstetrics and Gynecology · doi:10.1097/aog.0b013e31827374e2 · Cited by 152
Demeestere, I., Brice, P., Peccatori, F. A., Kentos, A., Gaillard, I., Zachée, P., Casasnovas, O., Neste, É. V. D., Dechène, J., Maertelaer, V. D., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2012.42.8185 · Cited by 129
Elgindy, E. A., Sibai, H., Abdelghani, A., & Mostafa, M. I. (2015) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000000905 · Cited by 118
Lambertini, M., Cinquini, M., Moschetti, I., Peccatori, F. A., Anserini, P., Menada, M. V., Tomirotti, M., & Mastro, L. D. (2016) · European Journal of Cancer · doi:10.1016/j.ejca.2016.10.034 · Cited by 95
Turner, N. H., Partridge, A. H., Sanna, G., Leo, A. D., & Biganzoli, L. (2013) · Annals of Oncology · doi:10.1093/annonc/mdt196 · Cited by 93
Self-citation
Cited by
Cancer treatment and survivorship statistics, 2019
Miller, K. D., Nogueira, L., Mariotto, A. B., Rowland, J. H., Yabroff, K. R., Alfano, C. M., Jemal, A., Kramer, J. L., & Siegel, R. L. (2019) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21565 · Cited by 4,226
Cancer treatment and survivorship statistics, 2022
Miller, K. D., Nogueira, L., Devasia, T., Mariotto, A. B., Yabroff, K. R., Jemal, A., Kramer, J., & Siegel, R. L. (2022) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21731 · Cited by 3,597
Breast Cancer, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology
Gradishar, W. J., Anderson, B. O., Abraham, J., Aft, R., Agnese, D., Allison, K. H., Blair, S. L., Burstein, H. J., Dang, C., Elias, A. D., et al. (2020) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2020.0016 · Cited by 1,584
Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Filetti, S., Durante, C., Hartl, D., Leboulleux, S., Locati, L. D., Newbold, K., Papotti, M. G., & Berruti, A. (2019) · Annals of Oncology · doi:10.1093/annonc/mdz400 · Cited by 1,200
Sammaritano, L. R., Bermas, B. L., Chakravarty, E. E., Chambers, C., Clowse, M. E. B., Lockshin, M. D., Marder, W., Guyatt, G., Branch, D. W., Buyon, J., et al. (2020) · Arthritis & Rheumatology · doi:10.1002/art.41191 · Cited by 790
Metadata
- Authors
- Oktay, K., Harvey, B. E., Partridge, A. H., Quinn, G. P., Reinecke, J., Taylor, H. S., Wallace, W. H., Wang, E. T., & Loren, A. W.
- Venue
- Journal of Clinical Oncology
- Published
- 2018-07-01
- Volume
- 36
- Issue
- 19
- Pages
- 1994-2001
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2795588819
- Cited by
- 1,486
- References
- 28
- FWCI
- 136.55
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.